Hugel, Inc. (KOSDAQ:145020)
198,500
+5,900 (3.06%)
Nov 18, 2026, 3:30 PM KST
Hugel Market Cap
Hugel has a market cap or net worth of 2.19 trillion as of November 17, 2026. It is the 7,346th most valuable company in the world and the 163rd biggest in South Korea. Its market cap has decreased by 13.87% in one year.
Market Cap
2.19T
Enterprise Value
1.64T
Revenue
471.17B
Global Rank
Country Rank
#163 South Korea
PE Ratio
17.22
ChartMarket Cap Chart
Since December 24, 2015, Hugel's market cap has increased from 552.70B to 2.19T, an increase of 295.58%. That is a compound annual growth rate of 13.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2026 | 2.19T | -12.18% |
| Dec 30, 2025 | 2.49T | -19.40% |
| Dec 30, 2024 | 3.09T | 84.38% |
| Dec 28, 2023 | 1.68T | 4.84% |
| Dec 29, 2022 | 1.60T | -14.29% |
| Dec 30, 2021 | 1.86T | -20.74% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SK Biopharmaceuticals | 6.73T |
| HLB Co., Ltd. | 3.61T |
| SK bioscience | 2.98T |
| ABL Bio | 2.02T |
| LigaChem Biosciences | 1.99T |
| Peptron | 1.96T |
| Voronoi | 1.85T |
| OliX Pharmaceuticals | 1.79T |